We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Single-Use System Enables Minimally Invasive Decompression for Lumbar Spinal Stenosis

By HospiMedica International staff writers
Posted on 07 Apr 2026

Lumbar spinal stenosis is frequently driven by hypertrophic bone that narrows the canal and produces pain. More...

Conventional decompression often relies on larger incisions and bulky retractors, adding time, bioburden risk, and the potential for scarring and protracted recovery; other minimally invasive options may focus mainly on soft tissue and fall short when bone overgrowth predominates. There is ongoing need for targeted bony decompression with consistent visualization and workflow. A new system now offers a fully disposable approach to minimally invasive lumbar decompression following U.S. Food and Drug Administration 510(k) clearance.

Allevion Medical’s Vantage is a fully disposable, sterile system for minimally invasive lumbar decompression. Cleared via the U.S. Food and Drug Administration (FDA) 510(k) pathway, it is designed to simplify procedural steps and eliminate the need for additional instruments or sterile processing. The kit is intended to streamline setup while supporting reproducibility in ambulatory surgery centers and hospitals.

The system’s operation follows an intuitive, reproducible sequence—locate, dilate, decompress—to help physicians perform the procedure with greater consistency and efficiency. It enables targeted removal of hypertrophic bone from the lamina and facet joints that may contribute to spinal canal narrowing. Direct visualization is supported by single‑use integrated illumination, enhancing procedural control and precision.

Instrumentation within the kit is engineered for depth‑controlled bone resection while protective guards are designed to help reduce the risk of injury to delicate structures. The minimally invasive approach aims to limit tissue disruption compared with traditional decompression that can require larger incisions and bulky instrumentation. By removing the need for reprocessing and multiple instrument trays, the design also addresses time, cost, and potential bioburden concerns.

According to the company, the single‑use design, structured workflow, and integrated visualization collectively provide a streamlined and reliable option for treating lumbar spinal stenosis. These features are intended to support efficiency, control, and consistency throughout spinal decompression procedures.

Related Links
Allevion Medical


Gold Member
Blood Gas Analyzer
i-Check200
Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Breast Imaging Monitor
Barco Coronis Onelook MDMC-32133 32MP
X-Ray Generator
Advantage Plus Generators
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Critical Care

view channel
Image: The investigational niia signature wearable patch combines continuous glucose monitoring, insulin delivery, and automated glucose control in a single system. (photo courtesy of PharmaSens)

Wearable Patch Prototype Advances Toward Integrated Automated Insulin Delivery

Diabetes management requires individualized care, reliable glucose and ketone monitoring, and timely intervention. For automated insulin delivery, a key challenge is maintaining accurate glucose measurements... Read more

Patient Care

view channel
Image Credit: Adobe Stock

AI Platform Personalizes Support Between Visits for Cancer Survivors

Cancer survivors often manage persistent side effects after treatment, including fatigue, anxiety, uncertainty, symptoms, stress, and questions between appointments. Clinical teams need ways to maintain... Read more

Medical Imaging

view channel
Image: Visual Abstract (Andrea Farolfi et al., Journal of Nuclear Medicine, 2026. DOI: 10.2967/jnumed.126.272108)

PSMA PET/CT-Guided Biopsy Improves Detection of Significant Prostate Cancer After Nondiagnostic MRI

Prostate cancer can be difficult to detect when magnetic resonance imaging (MRI) findings are negative or inconclusive. Men with persistent clinical risk factors may still require biopsy, yet standard... Read more

Point of Care

view channel
Image Credit: 123RF

Continuous Glucose Monitoring Identifies Cardiometabolic Risk in Adults Without Diabetes

Dysglycemia—abnormal blood glucose regulation—can fluctuate throughout the day and often escape conventional screening. Clinicians typically rely on fasting plasma glucose and hemoglobin A1c, which offer... Read more

Business

view channel
Image: WHX returns to Dubai Exhibition Centre, Expo City, and Dubai World Trade Centre from 5–28 January 2027 (Photo courtesy of World Health Expo)

World Health Expo to Showcase Trillion-Dollar Growth Across Pharma, Biotech, Longevity and Wellness at 2027 Edition

World Health Expo (WHX) expands with the new Pharma, Biotech, Longevity and Wellness industry sectors More than 235,000 professional visits, over 4,200 exhibitors and representatives from over... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.